Adaptive Bio ADPT Stock Market Risk 232 20260427 Enliven Therapeutics ELVN Stock Industry Opportunities 082 20260427 BCSS Bain Cap GSS CEO prioritizes expansion of alternative asset offerings to drive longterm revenue growth Aon plc AON PreEarnings Analysis Mixed Signals Ahead of Q1 2026 Results ADPT Adaptive Bio posts narrower than expected Q4 2025 loss shares rise 232 percent on investor optimism